HK1049335B - 神經氨酸化合物的水合物和結晶體 - Google Patents

神經氨酸化合物的水合物和結晶體

Info

Publication number
HK1049335B
HK1049335B HK03101448.3A HK03101448A HK1049335B HK 1049335 B HK1049335 B HK 1049335B HK 03101448 A HK03101448 A HK 03101448A HK 1049335 B HK1049335 B HK 1049335B
Authority
HK
Hong Kong
Prior art keywords
hydrates
crystals
acid compound
neuraminic acid
compound
Prior art date
Application number
HK03101448.3A
Other languages
English (en)
Other versions
HK1049335A1 (en
Inventor
Murakami Masayuki
Watanabe Masashi
Honda Takeshi
Yamaoka Makoto
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1049335A1 publication Critical patent/HK1049335A1/xx
Publication of HK1049335B publication Critical patent/HK1049335B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
HK03101448.3A 2000-04-25 2003-02-27 神經氨酸化合物的水合物和結晶體 HK1049335B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000123807 2000-04-25
PCT/JP2001/003583 WO2001081331A1 (fr) 2000-04-25 2001-04-25 Hydrates et cristaux d'un compose d'acide neuraminique

Publications (2)

Publication Number Publication Date
HK1049335A1 HK1049335A1 (en) 2003-05-09
HK1049335B true HK1049335B (zh) 2005-03-11

Family

ID=18634042

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101448.3A HK1049335B (zh) 2000-04-25 2003-02-27 神經氨酸化合物的水合物和結晶體

Country Status (12)

Country Link
US (1) US6844363B2 (zh)
EP (1) EP1277750B1 (zh)
AT (1) ATE279404T1 (zh)
AU (2) AU2001252579B2 (zh)
CA (1) CA2407468C (zh)
DE (1) DE60106421T2 (zh)
ES (1) ES2228848T3 (zh)
HK (1) HK1049335B (zh)
PT (1) PT1277750E (zh)
TR (1) TR200402776T4 (zh)
TW (1) TWI291462B (zh)
WO (1) WO2001081331A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
WO2002092555A1 (fr) * 2001-05-11 2002-11-21 Sankyo Company, Limited Derives d'acides sialiques
WO2005090334A2 (en) 2004-03-12 2005-09-29 Vertex Pharmaceuticals Incorporated Processes and intermediates for the preparation of aspartic acetal caspase inhibitors
US7776869B2 (en) 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
KR101473028B1 (ko) * 2007-03-07 2014-12-15 다이이찌 산쿄 가부시키가이샤 인플루엔자 치료제
TWI460182B (zh) 2007-04-11 2014-11-11 Daiichi Sankyo Co Ltd 原酸酯之製造方法
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CN101787008A (zh) * 2009-01-23 2010-07-28 中国科学院上海药物研究所 N-乙酰神经氨酸类化合物、其药物组合物及其制备方法和用途
ES2640001T3 (es) 2011-12-16 2017-10-31 Daiichi Sankyo Company, Limited Procedimiento de producción de un derivado del ácido neuramínico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2745059B2 (ja) * 1989-03-08 1998-04-28 メクト株式会社 Ｎ―アセチルノイラミン酸ナトリウム・三水和物
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
ATE211468T1 (de) * 1996-07-22 2002-01-15 Sankyo Co Neuraminsäuredervate, ihre herstellung und medizinische verwendung

Also Published As

Publication number Publication date
TWI291462B (en) 2007-12-21
HK1049335A1 (en) 2003-05-09
EP1277750B1 (en) 2004-10-13
US6844363B2 (en) 2005-01-18
DE60106421D1 (de) 2004-11-18
CA2407468A1 (en) 2002-10-23
ES2228848T3 (es) 2005-04-16
WO2001081331A1 (fr) 2001-11-01
DE60106421T2 (de) 2005-06-30
PT1277750E (pt) 2004-12-31
EP1277750A1 (en) 2003-01-22
TR200402776T4 (tr) 2004-12-21
AU5257901A (en) 2001-11-07
CA2407468C (en) 2009-06-30
ATE279404T1 (de) 2004-10-15
EP1277750A4 (en) 2003-05-28
AU2001252579B2 (en) 2004-09-30
US20030105158A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
DE60315265D1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
CA2299355A1 (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
IL143545A (en) Thrombin inhibitors and pharmaceutical compositions containing them
AU7862794A (en) 2,3-diaminopropionic acid derivative
CA2418770A1 (en) Acylacetonitrile compound, process for preparation thereof, and miticide containing the same
SE9802974D0 (sv) New crystalline forms
EP1314712A4 (en) NF-KAPPA-B INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT
WO1999000373A8 (fr) Derives de benzimidazole
EP1110961A4 (en) OXYGEN HETEROCYCLIC COMPOUNDS
HK1049335A1 (en) Hydrates and crystals of a neuraminic acid compound.
AU2722095A (en) Novel pyrrolocarbazoles
EP1241158A4 (en) HYDROXYCARBONYL-HALOGENOALKYLE SIDE CHAIN COMPOUND
WO2002083616A1 (fr) DERIVE D'ACIDE GRAS φomega;-ARYLE α-SUBSTITUE
AU9025601A (en) Cephem compounds and esbl-detecting reagents containing the same
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
DE60230781D1 (en) Reverse hydroxamsäurederivate
EP1099690A4 (en) MONOCYCLIC BETA LACTAM COMPOUNDS AND CHYMASE INHIBITORS THAT CONTAIN THEM
DE60116514D1 (de) Amlodipin-hemimaleat
EP1118615A4 (en) PYRIDOPYRAZINE DERIVATIVES SALTS AND CRYSTALS THEREOF
EP1319658A4 (en) IMIDAZOLE DERIVATIVES OR THEIR SALTS
CA2245484A1 (en) Novel urea derivatives
HK1053793A1 (en) Pharmaceutical compositions containing oxapenem-3-carboxilic acids
EP1118327A4 (en) PREVENTIVE AND / OR THERAPEUTIC AGENTS FOR THE TREATMENT OF SINUSITIS.
MXPA05011840A (es) Procedimiento para cristalizar sales de guanidinio.
TH60760A (th) รูปแบบผลึกแบบใหม่

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20210424